Arrhythmias & electrophysiology

Predicting Outcomes in Pediatric Intraluminal Pulmonary Vein Stenosis Using a Comprehensive Standardized Catheterization Assessment: A Prospective Study

Circ Cardiovasc IntervPublished prospective trial

Authors' conclusion

A multimodal pulmonary vein catheterization assessment determined angiographic and intravascular ultrasound findings to be the most predictive of 12-month pulmonary vein outcome.

Study context

Population
Patients under 13 years of age undergoing cardiac catheterization for pediatric intraluminal pulmonary vein stenosis (PVS)patients, 200 veins by angiography · angiography (veins) 200 · pressure assessment 171 · intravascular ultrasound 169 · balloon compliance testing 58 · wall shear stress calculations 141
Participants
50 participants
Exposure
Multimodal catheterization characteristics (angiography, pulmonary vein pressure, intravascular ultrasound, balloon compliance testing, wall shear stress) and their association with vein outcomes
Outcome
Worse vein outcome (vein status assigned by an end point committee)
Follow-up
12 months
Methodological detailsstandardized catheterization assessment
  • Standardized catheterization assessment

Main finding

As reported in the abstract

Multivariable analysis
Odds ratio (95% CI)P value
Angiographic upstream luminal narrowing
3.26(1.38–7.7)
P = 0.007
Ostial diameter <6 mm
3.93(1.29–12)
P = 0.016
≥35% upstream wall thickness by intravascular ultrasound
5.05(2.03–12.5)
P < 0.001

Observational data: associations, not effects.

Secondary outcomes

Transplant-free survival (secondary outcome) · 12 months

Transplant-free survival
92%

Original publication

Predicting Outcomes in Pediatric Intraluminal Pulmonary Vein Stenosis Using a Comprehensive Standardized Catheterization Assessment: A Prospective Study. Circ Cardiovasc Interv. Published 14 July 2025. doi:10.1161/circinterventions.124.015002

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.